Medical Devices

United States Nuclear Medicine Therapeutics Market Report 2017

  • QYR904513
  • 120 Pages
  • February 2017
  • Medical Devices
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Nuclear Medicine Therapeutics

Revenue, means the sales value of Nuclear Medicine Therapeutics

This report studies sales (consumption) of Nuclear Medicine Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

IBA Group

Lantheus Medical Imaging

Triad Isotopes

Siemens Healthcare (PETNET Solutions)

NTP Radioisotopes

Market Segment by States, covering

California

Texas

New York

Florida

Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Alpha Emitters

Beta Emitters

Brachytherapy

Split by applications, this report focuses on sales, market share and growth rate of Nuclear Medicine Therapeutics in each application, can be divided into

Application 1

Application 2

Table of Contents

United States Nuclear Medicine Therapeutics Market Report 2017

1 Nuclear Medicine Therapeutics Overview

1.1 Product Overview and Scope of Nuclear Medicine Therapeutics

1.2 Classification of Nuclear Medicine Therapeutics

1.2.1 Alpha Emitters

1.2.2 Beta Emitters

1.2.3 Brachytherapy

1.3 Application of Nuclear Medicine Therapeutics

1.3.1 Application 1

1.3.2 Application 2

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Nuclear Medicine Therapeutics (2012-2022)

1.4.1 United States Nuclear Medicine Therapeutics Sales and Growth Rate (2012-2022)

1.4.2 United States Nuclear Medicine Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Nuclear Medicine Therapeutics Competition by Manufacturers

2.1 United States Nuclear Medicine Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Nuclear Medicine Therapeutics Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Nuclear Medicine Therapeutics Average Price by Manufactures (2015 and 2016)

2.4 Nuclear Medicine Therapeutics Market Competitive Situation and Trends

2.4.1 Nuclear Medicine Therapeutics Market Concentration Rate

2.4.2 Nuclear Medicine Therapeutics Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Nuclear Medicine Therapeutics Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Nuclear Medicine Therapeutics Sales and Market Share by States (2012-2017)

3.2 United States Nuclear Medicine Therapeutics Revenue and Market Share by States (2012-2017)

3.3 United States Nuclear Medicine Therapeutics Price by States (2012-2017)

4 United States Nuclear Medicine Therapeutics Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Nuclear Medicine Therapeutics Sales and Market Share by Type (2012-2017)

4.2 United States Nuclear Medicine Therapeutics Revenue and Market Share by Type (2012-2017)

4.3 United States Nuclear Medicine Therapeutics Price by Type (2012-2017)

4.4 United States Nuclear Medicine Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Nuclear Medicine Therapeutics Sales (Volume) by Application (2012-2017)

5.1 United States Nuclear Medicine Therapeutics Sales and Market Share by Application (2012-2017)

5.2 United States Nuclear Medicine Therapeutics Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Nuclear Medicine Therapeutics Manufacturers Profiles/Analysis

6.1 IBA Group

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Nuclear Medicine Therapeutics Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 IBA Group Nuclear Medicine Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Lantheus Medical Imaging

6.2.2 Nuclear Medicine Therapeutics Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Lantheus Medical Imaging Nuclear Medicine Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Triad Isotopes

6.3.2 Nuclear Medicine Therapeutics Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Triad Isotopes Nuclear Medicine Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Siemens Healthcare (PETNET Solutions)

6.4.2 Nuclear Medicine Therapeutics Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 NTP Radioisotopes

6.5.2 Nuclear Medicine Therapeutics Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 NTP Radioisotopes Nuclear Medicine Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

7 Nuclear Medicine Therapeutics Manufacturing Cost Analysis

7.1 Nuclear Medicine Therapeutics Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Nuclear Medicine Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Nuclear Medicine Therapeutics Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Nuclear Medicine Therapeutics Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Nuclear Medicine Therapeutics Market Forecast (2017-2022)

11.1 United States Nuclear Medicine Therapeutics Sales, Revenue Forecast (2017-2022)

11.2 United States Nuclear Medicine Therapeutics Sales Forecast by Type (2017-2022)

11.3 United States Nuclear Medicine Therapeutics Sales Forecast by Application (2017-2022)

11.4 Nuclear Medicine Therapeutics Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Nuclear Medicine Therapeutics

Table Classification of Nuclear Medicine Therapeutics

Figure United States Sales Market Share of Nuclear Medicine Therapeutics by Type in 2015

Figure Alpha Emitters Picture

Figure Beta Emitters Picture

Figure Brachytherapy Picture

Table Application of Nuclear Medicine Therapeutics

Figure United States Sales Market Share of Nuclear Medicine Therapeutics by Application in 2015

Figure United States Nuclear Medicine Therapeutics Sales and Growth Rate (2012-2022)

Figure United States Nuclear Medicine Therapeutics Revenue and Growth Rate (2012-2022)

Table United States Nuclear Medicine Therapeutics Sales of Key Manufacturers (2015 and 2016)

Table United States Nuclear Medicine Therapeutics Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Nuclear Medicine Therapeutics Sales Share by Manufacturers

Figure 2016 Nuclear Medicine Therapeutics Sales Share by Manufacturers

Table United States Nuclear Medicine Therapeutics Revenue by Manufacturers (2015 and 2016)

Table United States Nuclear Medicine Therapeutics Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Nuclear Medicine Therapeutics Revenue Share by Manufacturers

Table 2016 United States Nuclear Medicine Therapeutics Revenue Share by Manufacturers

Table United States Market Nuclear Medicine Therapeutics Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Nuclear Medicine Therapeutics Average Price of Key Manufacturers in 2015

Figure Nuclear Medicine Therapeutics Market Share of Top 3 Manufacturers

Figure Nuclear Medicine Therapeutics Market Share of Top 5 Manufacturers

Table United States Nuclear Medicine Therapeutics Sales by States (2012-2017)

Table United States Nuclear Medicine Therapeutics Sales Share by States (2012-2017)

Figure United States Nuclear Medicine Therapeutics Sales Market Share by States in 2015

Table United States Nuclear Medicine Therapeutics Revenue and Market Share by States (2012-2017)

Table United States Nuclear Medicine Therapeutics Revenue Share by States (2012-2017)

Figure Revenue Market Share of Nuclear Medicine Therapeutics by States (2012-2017)

Table United States Nuclear Medicine Therapeutics Price by States (2012-2017)

Table United States Nuclear Medicine Therapeutics Sales by Type (2012-2017)

Table United States Nuclear Medicine Therapeutics Sales Share by Type (2012-2017)

Figure United States Nuclear Medicine Therapeutics Sales Market Share by Type in 2015

Table United States Nuclear Medicine Therapeutics Revenue and Market Share by Type (2012-2017)

Table United States Nuclear Medicine Therapeutics Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Nuclear Medicine Therapeutics by Type (2012-2017)

Table United States Nuclear Medicine Therapeutics Price by Type (2012-2017)

Figure United States Nuclear Medicine Therapeutics Sales Growth Rate by Type (2012-2017)

Table United States Nuclear Medicine Therapeutics Sales by Application (2012-2017)

Table United States Nuclear Medicine Therapeutics Sales Market Share by Application (2012-2017)

Figure United States Nuclear Medicine Therapeutics Sales Market Share by Application in 2015

Table United States Nuclear Medicine Therapeutics Sales Growth Rate by Application (2012-2017)

Figure United States Nuclear Medicine Therapeutics Sales Growth Rate by Application (2012-2017)

Table IBA Group Basic Information List

Table IBA Group Nuclear Medicine Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Figure IBA Group Nuclear Medicine Therapeutics Sales Market Share (2012-2017)

Table Lantheus Medical Imaging Basic Information List

Table Lantheus Medical Imaging Nuclear Medicine Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Lantheus Medical Imaging Nuclear Medicine Therapeutics Sales Market Share (2012-2017)

Table Triad Isotopes Basic Information List

Table Triad Isotopes Nuclear Medicine Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Triad Isotopes Nuclear Medicine Therapeutics Sales Market Share (2012-2017)

Table Siemens Healthcare (PETNET Solutions) Basic Information List

Table Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Sales Market Share (2012-2017)

Table NTP Radioisotopes Basic Information List

Table NTP Radioisotopes Nuclear Medicine Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table NTP Radioisotopes Nuclear Medicine Therapeutics Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Nuclear Medicine Therapeutics

Figure Manufacturing Process Analysis of Nuclear Medicine Therapeutics

Figure Nuclear Medicine Therapeutics Industrial Chain Analysis

Table Raw Materials Sources of Nuclear Medicine Therapeutics Major Manufacturers in 2015

Table Major Buyers of Nuclear Medicine Therapeutics

Table Distributors/Traders List

Figure United States Nuclear Medicine Therapeutics Production and Growth Rate Forecast (2017-2022)

Figure United States Nuclear Medicine Therapeutics Revenue and Growth Rate Forecast (2017-2022)

Table United States Nuclear Medicine Therapeutics Production Forecast by Type (2017-2022)

Table United States Nuclear Medicine Therapeutics Consumption Forecast by Application (2017-2022)

Table United States Nuclear Medicine Therapeutics Sales Forecast by States (2017-2022)

Table United States Nuclear Medicine Therapeutics Sales Share Forecast by States (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370